THIS IS THE FACE OF ADVANCED BCC TODAY

Basal cell carcinomas can recur in some patients, and subsequent treatment can be difficult.[1-3] When the BCC advances and you're running out of treatment options...

WHAT'S NEXT FOR THESE PATIENTS?

For More Information: Register Now
http://interactive.genentech.com/content/emedia/view/SkinCancer-Opt-In.view.html?cid=3000HHHSDS

Genentech is investigating the molecular basis of skin cancers such as advanced BCC.

References: 1. Rowe DE. Comparison of treatment modalities for basal cell carcinoma. Clin Dermatol. 1995;13:617-620. 2. Chew R. Destruction of the orbit and globe by recurrence of basal cell carcinoma. Optometry. 2007;78:344-351. 3. Robinson JK, Fisher SG. Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol. 2000;136:1318-1324.

To view the Privacy Policy, please copy and paste the URL below into a Web browser:
http://www.gene.com/gene/privacy.html?cid=3000HHHSDS

To view the Terms and Conditions, please copy and paste the URL below into a Web browser:
http://www.gene.com/gene/terms.html?cid=3000HHHSDS

To contact Genentech[R], please copy and paste the URL below into a Web browser:
http://www.gene.com/gene/contact/san-francisco.html?cid=3000HHHSDS

To visit Genentech[R], please copy and paste the URL below into a Web browser:
http://www.gene.com/gene/index.jsp?cid=3000HHHSDS

This e-mail is intended for U.S. healthcare professionals only.

Genentech USA, Inc.
1 DNA Way
South San Francisco, CA
94080-4990

Copyright 2011 Genentech USA, Inc. All rights reserved.

To unsubscribe from the Genentech mailing list, please copy and paste the URL below into a Web browser:
http://interactive.genentech.com/content/emedia/view/SkinCancer-Opt-Out.view.html?cid=3000HHHSDS

HED0000567700